Form 8-K - Current report:
SEC Accession No. 0001213900-25-057233
Filing Date
2025-06-24
Accepted
2025-06-24 16:05:40
Documents
32
Period of Report
2025-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246748-8k_hoth.htm   iXBRL 8-K 24864
2 PRESENTATION MATERIALS DATED JUNE 2025 ea024674801ex99-1_hoth.htm EX-99.1 16787
3 GRAPHIC ex99-1_001.jpg GRAPHIC 174268
4 GRAPHIC ex99-1_002.jpg GRAPHIC 819560
5 GRAPHIC ex99-1_003.jpg GRAPHIC 258795
6 GRAPHIC ex99-1_004.jpg GRAPHIC 720191
7 GRAPHIC ex99-1_005.jpg GRAPHIC 537788
8 GRAPHIC ex99-1_006.jpg GRAPHIC 681835
9 GRAPHIC ex99-1_007.jpg GRAPHIC 380028
10 GRAPHIC ex99-1_008.jpg GRAPHIC 738645
11 GRAPHIC ex99-1_009.jpg GRAPHIC 310933
12 GRAPHIC ex99-1_010.jpg GRAPHIC 426575
13 GRAPHIC ex99-1_011.jpg GRAPHIC 126182
14 GRAPHIC ex99-1_012.jpg GRAPHIC 799397
15 GRAPHIC ex99-1_013.jpg GRAPHIC 600330
16 GRAPHIC ex99-1_014.jpg GRAPHIC 859239
17 GRAPHIC ex99-1_015.jpg GRAPHIC 320296
18 GRAPHIC ex99-1_016.jpg GRAPHIC 612639
19 GRAPHIC ex99-1_017.jpg GRAPHIC 458255
20 GRAPHIC ex99-1_018.jpg GRAPHIC 437506
21 GRAPHIC ex99-1_019.jpg GRAPHIC 221076
  Complete submission text file 0001213900-25-057233.txt   13275818

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE hoth-20250624.xsd EX-101.SCH 3038
23 XBRL LABEL FILE hoth-20250624_lab.xml EX-101.LAB 34239
24 XBRL PRESENTATION FILE hoth-20250624_pre.xml EX-101.PRE 22374
34 EXTRACTED XBRL INSTANCE DOCUMENT ea0246748-8k_hoth_htm.xml XML 3816
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 251068994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)